Ori Biotech
Series BLondon, UKJan 2022
Ori Biotech raised €88M in a Series B round in Jan 2022. The company is based in London, UK. Investors in the round: Amadeus Capital Partners, Chimera Partners, Delin Ventures and 4 others. Data as of Nov 2026.
Amount raised
€88M
€87,973,960
Native amount
100,000,000 USD
Stage
Series B
series b
Investors
7
Provenance & confidence
High confidenceAmount
100,000,000 USD
ECB-at-date → €88M · rate 1.1367 on 2022-01-18
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
7 namedAmadeus Capital PartnersChimera PartnersDelin VenturesNorthpond VenturesNovalis LifeSciencesOctopus VenturesPuhua Capital
Date
Jan 2022
Round type
series b
Amount (EUR)
€88M
Other rounds
same companyRelated news
- Ori Biotech Raises Over USD100M in Series B Fundingfinsmes.com · 2022-01